Hims & Hers stock plunges after weight loss pill pulled amid FDA scrutiny
Stocks for Hims & Hers fell on Monday after the company pulled its $49 weight loss pill that's under FDA scrutiny. Yahoo Finance senior reporter Brooke DiPalma joined CBS News to talk about that and some of the other top financial headlines.
AI brief
Pulse reads the full article- What happened
- Why it matters
- What to watch
Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.
Sign in to read the brief
